All In Biotech

Free tool

FAERS Monitor: Tavneos

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214487 or its brand name (Tavneos, Avacopan). Reports on generic versions are filed under their own applications.

Reports

6,762

Serious

5,036

74% of reports

Hospitalization

3,168

Death reported

691

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hospitalisation1,026
  • death414
  • off label use373
  • therapy interrupted354
  • diarrhoea272
  • fatigue270
  • nausea249
  • pneumonia245
  • headache183
  • covid-19176
  • product dose omission issue158
  • dialysis145
  • drug ineffective145
  • infection145
  • dyspnoea142

Reports by year received

View as table
YearReports
20218
2022462
20231,671
20241,242
20251,727
20261,652

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,397 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dialysisSignal14532.127.34,297
hospitalisationSignal1,02620.919.819,436
therapy interruptedSignal35415.514.04,773
covid-19Signal1763.12.7254
infectionSignal1453.12.7208
pneumoniaSignal2452.42.1192
product dose omission issue1581.71.443
death4141.51.470
off label use3731.31.231
diarrhoea2721.31.220
fatigue2701.11.02
nausea2491.00.90
headache1830.90.82
dyspnoea1420.80.79
drug ineffective1450.30.3195

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.